Skip to content
DEPARTMENT PROFILE

Nishimura & Asahi

Life Sciences

1 ranked lawyersBand 2JapanAsia-Pacific 2022 View ranking table
chambers review
department information
Ranked Lawyers
chambers review
department information
Ranked Lawyers

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Nishimura & Asahi has a well-established practice assisting an international roster of pharmaceutical and medical device companies, as well as academic institutions and major distributors. Especially known for covering cross-border M&A, joint ventures and restructuring matters, alongside advice on regulatory matters and clinical trials. Ably handles IP rights, licensing and compliance issues in the life sciences space. Also represents clients in contentious matters such as patent infringement disputes. Its key clients include Takeda Pharmaceutical, Shionogi & Co, and Danaher Corporation.

Strengths

One satisfied client says: "There are many experts in the firm and they are familiar with the industry so they provide us with realistic advice rather than a so-called 'critic's opinion'."

Another impressed client comments: "The Nishimura & Asahi lawyers have a deep understanding of the pharmaceutical business and provide us with proposals that lead to solutions."

Work highlights

Nishimura & Asahi represented Takeda Pharmaceutical on the JPY242 billion sale of its subsidiary Takeda Consumer Healthcare, to an acquisition company controlled by funds managed by Blackstone Group.

Notable practitioners

Mariko Mimura leverages her former role for the Japan branch of a major global pharmaceutical company and is well known for her expertise in handling pharmaceutical regulatory matters. "She has long-term experience in working in the healthcare sector as in-house counsel and provides us with extremely effective advice," remarks one source.

Department Information

This content is provided by Nishimura & Asahi.

Overview

Our Life Science and Healthcare Group offers a variety of legal services to domestic and international clients, including advising on issues regarding licensing, approvals, notifications, etc., compliance, risk management raised by non-compliance, defective product recalls, and information management and intellectual property rights in the medical field, healthcare field (including food and beverage fields), and the medicine and medical device fields, based on applicable laws such as the Pharmaceuticals Medical Machinery, etc. Act, the Medical Care Act, the Medical Practitioners Act, the Food Sanitation Act, and the Health Promotion Act.  In addition, our Life Science and Healthcare Group has undertaken various M&A cases, taking advantage of the group’s broad knowledge, and provided strategic advice.  We provide advice on a broad range of cases, including business mergers, joint ventures, acquisitions, and restructuring among pharmaceutical companies and medical device companies.  As one example, we have advised Takeda Pharmaceutical Co., Ltd., the largest pharmaceutical company in Asia, on its transaction to acquire all of the issued and to-be-issued ordinary share capital of Shire plc, a Jersey-registered and Dublin, Ireland-headquartered global specialty biopharmaceutical company.

Members

Date, Takahiko

Igaki, Taisuke

Kasai, Yoko

Mimura, Mariko

Shibata, Hiroko

Shinkawa, Asa

Suzuki, Gaku

Life Sciences

Nishimura & Asahi

firm
Location

Otemon Tower

1-1-2 Otemachi

Chiyoda-ku

Tokyo

Tokyo

Japan

100-8124

View Firm Profile

Ranked Lawyers

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

Japan

Life Sciences


Mariko Mimura
Band 3